Bio-Gene Technology Limited reports strong progress in advancing its Flavocide® and Qcide® insecticidal platforms, backed by US Department of Defense funding and key organic certification in the US.
Vection Technologies reports a 60% revenue surge in 1H25, secures a $21 million equity raise, and strengthens its position in defence AI and spatial computing with a robust $75 million sales pipeline.